273 related articles for article (PubMed ID: 21606286)
21. Staging of renal adenocarcinoma: role of various imaging procedures.
Zagoria RJ; Bechtold RE; Dyer RB
AJR Am J Roentgenol; 1995 Feb; 164(2):363-70. PubMed ID: 7839970
[TBL] [Abstract][Full Text] [Related]
22. Contemporary management of advanced renal cell carcinoma.
Khanna A; Crane A; Yerram N; Sun D; Ericson K; Lundy SD; Abouassaly R
Clin Adv Hematol Oncol; 2018 Jun; 16(6):438-446. PubMed ID: 30067615
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors and molecular markers for renal cell carcinoma.
Bui MH; Zisman A; Pantuck AJ; Han KR; Wieder J; Belldegrun AS
Expert Rev Anticancer Ther; 2001 Dec; 1(4):565-75. PubMed ID: 12113089
[TBL] [Abstract][Full Text] [Related]
24. [Adenocarcinoma of the kidney (hypernephroma)].
Probst W; Joss R; Triller J; Schönenberger A; Greiner R; Brunner KW
Schweiz Med Wochenschr; 1984 Oct; 114(41):1406-15. PubMed ID: 6208605
[TBL] [Abstract][Full Text] [Related]
25. [Clinical recommendations for treating and monitoring patients with renal cancer].
Petković M; Vrdoljak E; Ruzić IP; Belev B; Omrcen T; Ledina D; Tomek R; Ruzić B; Situm M; Buća A; Pisac VP;
Lijec Vjesn; 2012; 134(1-2):5-8. PubMed ID: 22519246
[TBL] [Abstract][Full Text] [Related]
26. [Staging and follow-up of renal cell carcinoma].
Rouvière O; Brunereau L; Lyonnet D; Rouleau P
J Radiol; 2002 Jun; 83(6 Pt 2):805-22, discussion 823-4. PubMed ID: 12218854
[TBL] [Abstract][Full Text] [Related]
27. [Are immunotherapy and chemotherapy in metastatic renal cell cancer out?].
Schmitz-Dräger BJ
Urologe A; 1992 Jul; 31(4):213-4. PubMed ID: 1514204
[No Abstract] [Full Text] [Related]
28. Genitourinary imaging: part 2, role of imaging in medical management of advanced renal cell carcinoma.
Shinagare AB; Krajewski KM; Jagannathan JP; Ramaiya NH
AJR Am J Roentgenol; 2012 Nov; 199(5):W554-64. PubMed ID: 23096199
[TBL] [Abstract][Full Text] [Related]
29. [Renal cell carcinoma: what is new in 2010?].
Tsaur I; Haferkamp A
Urologe A; 2011 Sep; 50 Suppl 1():216-8. PubMed ID: 21837489
[TBL] [Abstract][Full Text] [Related]
30. Current surgical approaches, nephron-sparing surgery, and the role of surgery in the integrated immunologic approach to renal-cell carcinoma.
Novick AC
Semin Oncol; 1995 Feb; 22(1):29-33. PubMed ID: 7855616
[No Abstract] [Full Text] [Related]
31. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Escudier B; Porta C; Schmidinger M; Rioux-Leclercq N; Bex A; Khoo V; Gruenvald V; Horwich A;
Ann Oncol; 2016 Sep; 27(suppl 5):v58-v68. PubMed ID: 27664262
[No Abstract] [Full Text] [Related]
32. [Renal cell carcinoma in the coming era of robotic technology].
Kolombo I; Ponesický J; Toberný M; Kríz R; Zemanová I; Weichet J; Vymazal J; Cernohorský S; Bartůnek M
Cas Lek Cesk; 2011; 150(4-5):215-22. PubMed ID: 21634198
[TBL] [Abstract][Full Text] [Related]
33. Is age a prognostic factor for treatment outcome in renal cell cancer-A comprehensive review.
Ramos-Barcelo E; Rioja J; Pes PL; de la Rosette JJ; de Reijke TM
Crit Rev Oncol Hematol; 2009 Oct; 72(1):83-9. PubMed ID: 19328009
[TBL] [Abstract][Full Text] [Related]
34. [Problems in the therapy of kidney neoplasms].
Masuda F
Nihon Hinyokika Gakkai Zasshi; 1985 Nov; 76(11):1612-8. PubMed ID: 3835352
[No Abstract] [Full Text] [Related]
35. New perspectives on the treatment of metastatic renal cell carcinoma: an introduction and historical overview.
Motzer RJ
Oncologist; 2011; 16 Suppl 2(Suppl 2):1-3. PubMed ID: 21346034
[TBL] [Abstract][Full Text] [Related]
36. Tissue array-based predictions of pathobiology, prognosis, and response to treatment for renal cell carcinoma therapy.
Lam JS; Belldegrun AS; Figlin RA
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6304S-9S. PubMed ID: 15448022
[TBL] [Abstract][Full Text] [Related]
37. [A case of synchronous ipsilateral renal cell carcinoma and ureteral transitional cell carcinoma].
Sugi M; Yamanaka S; Fujita I; Kawakita M; Matsuda T
Hinyokika Kiyo; 2000 Feb; 46(2):113-6. PubMed ID: 10769801
[TBL] [Abstract][Full Text] [Related]
38. Prognostic models and algorithms in renal cell carcinoma.
Lane BR; Kattan MW
Urol Clin North Am; 2008 Nov; 35(4):613-25; vii. PubMed ID: 18992615
[TBL] [Abstract][Full Text] [Related]
39. Treatment trends for stage I renal cell carcinoma.
Cooperberg MR; Mallin K; Kane CJ; Carroll PR
J Urol; 2011 Aug; 186(2):394-9. PubMed ID: 21679982
[TBL] [Abstract][Full Text] [Related]
40. [Interleukin 2 based ambulatory therapy of metastatic renal cell carcinoma].
Atzpodien J; Kirchner H; Poliwoda H
Med Klin (Munich); 1996 Apr; 91 Suppl 3():38-43. PubMed ID: 8692118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
